Sachan, Anjali, Gupta, Seema, Ghosh, Arunima, Singh, Navin. (1400). Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures. سامانه مدیریت نشریات علمی, 11(3), 403-406. doi: 10.31661/jbpe.v0i0.2011-1228
Anjali Sachan; Seema Gupta; Arunima Ghosh; Navin Singh. "Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures". سامانه مدیریت نشریات علمی, 11, 3, 1400, 403-406. doi: 10.31661/jbpe.v0i0.2011-1228
Sachan, Anjali, Gupta, Seema, Ghosh, Arunima, Singh, Navin. (1400). 'Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures', سامانه مدیریت نشریات علمی, 11(3), pp. 403-406. doi: 10.31661/jbpe.v0i0.2011-1228
Sachan, Anjali, Gupta, Seema, Ghosh, Arunima, Singh, Navin. Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures. سامانه مدیریت نشریات علمی, 1400; 11(3): 403-406. doi: 10.31661/jbpe.v0i0.2011-1228
Catering the Needs of Cancer Contemporary to this Contagious Corona Catastrophe: Institution Based Changes in Cancer Management and Protection Procedures
1MD, Department of Radiotherapy, King George’s Medical University, Lucknow, Uttar Pradesh, India
2PhD, Department of Radiotherapy, King George’s Medical University, Lucknow, Uttar Pradesh, India
چکیده
The COVID-19 global pandemic has drastically affected the health care facility worldwide, posing unprecedented challenges in front of the caregivers. All hospitals need adopt measures to protect patients and health professionals and to safely triage patients (according to country/regional directives) for identifying those infected with coronavirus. As very few guidelines are available for care of cancer patients during COVID times, institutes have had to make their own strategies, based on their own expertise keeping in mind local directives and their effect on available resources and routine processes to offer best possible care. In this article, we have discussed in-house protocols for modification and prioritization of radical and palliative multimodality treatment of cancer patients along with our infection control measures in accordance with national and local guidelines during COVID emergency to stay safe and health. Also, the current study aims to modify cancer treatment and care during the COVID-19 pandemic adhering and fulfilling all protective measures.
Machtay M, Hsu C, Komaki R, et al. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys. 2005;63(3):667-71. doi: 10.1016/j.ijrobp.2005.03.037. PubMed PMID: 15927409.
Thomson DJ, Palma D, Guckenberger M, et al. Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Int J Radiat Oncol Biol Phys. 2020;107(4):618-27. doi: 10.1016/j.ijrobp.2020.04.016. PubMed PMID: 32302681. PubMed PMCID: PMC7194855.
Vordermark D. Shift in indications for radiotherapy during the COVID-19 pandemic? A review of organ-specific cancer management recommendations from multidisciplinary and surgical expert groups. Radiat Oncol. 2020;15:1-4. doi: 10.1186/s13014-020-01579-3. PubMed PMID: 32493443. PubMed PMCID: PMC7267761.
Jones CM, Hawkins M, Mukherjee S, et al. Considerations for the treatment of oesophageal cancer with radiotherapy during the COVID-19 pandemic. Clin Oncol (R Coll Radiol). 2020;32(6):354-7. doi: 10.1016/j.clon.2020.04.001. PubMed PMID: 32299723. PubMed PMCID: PMC7144663.
Penel N, Bonvalot S, Minard V, Orbach D, et al. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak. Ann Oncol. 2020;31(7):965-6. doi: 10.1016/j.annonc.2020.03.308. PubMed PMID: 32278878. PubMed PMCID: PMC7144615.
Mohile NA, Blakeley JO, Gatson NT, et al. Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic. Neuro Oncol. 2020;22(7):912-7. doi: 10.1093/neuonc/noaa090. PubMed PMID: 32277236. PubMed PMCID: PMC7184330.
Curigliano G, Cardoso MJ, Poortmans P, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8-16. doi: 10.1016/j.breast.2020.04.006. PubMed PMID: 32334323. PubMed PMCID: PMC7162626.
Kutikov A, Weinberg DS, Edelman MJ, et al. A war on two fronts: cancer care in the time of COVID-19. Ann Intern Med. 2020;172(11):756-8. doi: 10.7326/M20-1133. PubMed PMID: 32219410. PubMed PMCID: PMC7133056.
Kamboj M, Hohl T, Vardhana S, et al. MSK COVID-19 VACCINE INTERIM GUIDELINES FOR CANCER PATIENTS. 2021. Available from: https://www.asco.org/sites/new-www.asco.org/files/content-files/covid-19/2021-MSK-COVID19-VACCINE-GUIDELINES.pdf.
European Society for Medical Oncology (ESMO). Cancer Patient Management During the COVID-19 Pandemic. ESMO; 2020. Available from: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic.
National Institutes of Health. COVID-19 Treatment Guidelines. NIH; 2020. Available from: https://www.covid19treatmentguidelines.nih.gov/special-populations/cancer/.
